Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Clinical value of serum squamous cell carcinoma antigen levels in predicting chemosensitivity, lymph node metastasis, and prognosis in patients with cervical squamous cell carcinoma

Fig. 2

Receiver operator characteristic (ROC) curve analysis showed the value of the percentage decrease in of SCC antigen levels in predicting the chemosensitivity of patients in the NACT group. FSCC (%): Percentage decrease in SCC antigen level after the first chemotherapy; TSCC (%): Percentage decrease in of SCC antigen level after total chemotherapy

Back to article page